1What is GERD?
Reflux of gastric contents into the esophagus causing symptoms or complications.
2What are the two classic symptoms of GERD?
Heartburn and regurgitation.
3How does GERD-related heartburn present?
Retrosternal burning pain.
4How does GERD-related regurgitation present?
Bitter or sour taste due to refluxed gastric contents.
5What is the most common type of hiatal hernia associated with GERD?
Sliding hiatal hernia.
6How does hiatal hernia contribute to GERD?
Disrupts the antireflux barrier and promotes LES dysfunction.
7What is the primary physiological abnormality in GERD?
Transient relaxation or decreased tone of the lower esophageal sphincter (LES).
8How does obesity contribute to GERD?
Increases intra-abdominal pressure.
9How does pregnancy contribute to GERD?
Progesterone decreases LES tone and the gravid uterus increases gastric pressure.
10Which medications can decrease LES tone?
Nitrates, calcium channel blockers, and anticholinergics.
11How does smoking contribute to GERD?
Decreases LES tone.
12How does alcohol contribute to GERD?
Relaxes the LES.
13What foods commonly aggravate GERD?
High-fat and fried foods.
14What are common extraesophageal manifestations of GERD?
Chronic cough, asthma, hoarseness, and chronic laryngitis.
15What is the initial diagnostic approach for uncomplicated GERD?
Clinical diagnosis based on typical symptoms.
16Is endoscopy routinely required for uncomplicated GERD?
No.
17What is the role of an empiric PPI trial in GERD?
Supports the diagnosis through symptom improvement.
18What are the alarm symptoms of GERD?
Dysphagia, odynophagia, weight loss, anemia, GI bleeding, and recurrent vomiting.
19When is upper endoscopy indicated in GERD?
Alarm symptoms or refractory symptoms.
20What does ambulatory pH monitoring measure?
Esophageal acid exposure.
21What does impedance-pH monitoring detect?
Acid and non-acid reflux.
22What is the initial treatment for erosive esophagitis?
Standard-dose PPI once daily for 8 weeks.
23When should PPIs be taken?
30–60 minutes before meals.
24What is the general principle when prescribing PPIs?
Use the lowest effective dose.
25What should be done when GERD symptoms persist despite once-daily PPI?
Check adherence and timing, then consider twice-daily dosing or switching PPIs.
26What is the role of alginate-antacid therapy in GERD?
Provides rapid relief of episodic and postprandial symptoms.
27When are H2-receptor blockers useful in GERD?
Intermittent symptom control or when PPIs are not tolerated.
28What is the most common mucosal complication of GERD?
Erosive esophagitis
29What are complications of erosive esophagitis?
Bleeding and peptic stricture.
30How does peptic esophageal stricture commonly present?
Progressive dysphagia to solids.
31What is Barrett's esophagus?
Replacement of distal esophageal squamous epithelium with intestinalized columnar epithelium.
32What is the characteristic endoscopic appearance of Barrett's esophagus?
Salmon-pink velvety mucosa
33What is the major complication of Barrett's esophagus?
Esophageal adenocarcinoma.
34What is the only recognized precursor lesion of esophageal adenocarcinoma?
Barrett's esophagus
35What histologic finding confirms intestinal metaplasia in Barrett's esophagus?
Goblet cells.
36What is the strongest clinical predictor of neoplastic progression in Barrett's esophagus?
Longer Barrett's segment.
37What are important risk factors for Barrett's esophagus?
Chronic GERD, male sex, obesity, advanced age, and central adiposity.
38What is the progression risk of Barrett's esophagus to adenocarcinoma per year?
Approximately 0.1–0.3%.
39What defines short-segment Barrett's esophagus?
Length less than 3 cm.
40What defines long-segment Barrett's esophagus?
Length of at least 3 cm.
41How is nondysplastic Barrett's esophagus managed?
Endoscopic surveillance.
42How is Barrett's esophagus with high-grade dysplasia managed?
Endoscopic eradication therapy, usually ablation.
43How is indefinite-for-dysplasia Barrett's esophagus initially managed?
Optimize acid suppression and repeat endoscopy.
44What is non-erosive reflux disease (NERD)?
Typical GERD symptoms without visible esophageal mucosal injury on endoscopy.
45What is the usual treatment for NERD?
PPI therapy.
46What is refractory GERD?
Persistent symptoms despite compliant twice-daily PPI therapy for at least 8 weeks.
47What should be checked before diagnosing refractory GERD?
Medication adherence, correct timing, and adequate dosing.
48What test is useful when endoscopy is normal in refractory GERD?
Ambulatory reflux monitoring.
49What is the mechanism of baclofen in refractory GERD?
Reduces transient LES relaxations.
50What is fundoplication?
Wrapping the proximal stomach around the distal esophagus to reinforce the antireflux barrier.
51What are complications of fundoplication?
Dysphagia, bloating, and gas-bloat syndrome.
52What tests should be performed before fundoplication?
Esophageal manometry and ambulatory reflux testing.
53How long should patients avoid lying down after meals to reduce GERD?
At least 3 hours.
54What lifestyle modification helps nocturnal GERD?
Elevating the head of the bed.
55What is peptic ulcer disease (PUD)?
A mucosal defect in the stomach or duodenum caused by acid-pepsin injury.
56What is the endoscopic definition of an ulcer?
A mucosal break greater than 5 mm.
57What is the endoscopic definition of an erosion?
A mucosal break smaller than 5 mm.
58What are the two major causes of PUD?
H. pylori infection and NSAID use
59What is the most common infectious cause of PUD?
Helicobacter pylori
60How is H. pylori transmitted?
Oral-oral and fecal-oral routes.
61What are the major risk factors for H. pylori infection?
Crowding, poor sanitation, and low socioeconomic status.
62How do NSAIDs cause peptic ulcers?
Inhibit prostaglandin synthesis and cause direct mucosal injury.
63What happens when gastric prostaglandins decrease?
Reduced mucus and bicarbonate secretion, impaired mucosal blood flow, and decreased epithelial repair.
64How does smoking affect PUD?
Increases acid secretion, impairs mucosal defenses, and delays ulcer healing.
65Does alcohol commonly cause PUD by itself?
No; it can aggravate mucosal injury.
66What is Zollinger-Ellison syndrome?
A gastrin-secreting tumor causing excessive gastric acid secretion.
67What is the characteristic ulcer pattern in Zollinger-Ellison syndrome?
Multiple or refractory peptic ulcers.
68What additional symptom commonly occurs in Zollinger-Ellison syndrome?
Diarrhea.
69What is the most frequent physical examination finding in PUD?
Epigastric tenderness
70What does a board-like abdomen suggest in a patient with PUD?
Perforation.
71What does a succussion splash suggest in PUD?
Gastric outlet obstruction.
72How does gastric ulcer pain relate to meals?
Often worsens after eating.
73How does duodenal ulcer pain relate to meals?
Improves with food and returns 90 minutes to 3 hours later.
74Which ulcer is more associated with nocturnal pain?
Duodenal ulcer.
75Which ulcer is more associated with early satiety and weight loss?
Gastric ulcer.
76Which ulcer has a greater concern for malignancy?
Gastric ulcer.
77Why must gastric ulcers be biopsied?
To exclude gastric malignancy.
78Where are most duodenal ulcers located?
First portion of the duodenum (D1).
79What is the usual acid output in gastric ulcer disease?
Normal or decreased.
80What is the usual acid output in duodenal ulcer disease?
Increased basal and nocturnal acid secretion.
81What is the primary pathophysiologic problem in gastric ulcers?
Impaired mucosal defenses.
82What is the most common complication of PUD?
Gastrointestinal bleeding
83What is the second most common complication of PUD?
Perforation.
84What is the classic presentation of perforated PUD?
Sudden severe abdominal pain with tachycardia and abdominal rigidity.
85What is ulcer penetration?
Extension of an ulcer into an adjacent organ without free perforation.
86Where do posterior duodenal ulcers commonly penetrate?
Pancreas.
87What is the least common major complication of PUD?
Gastric outlet obstruction.
88What causes gastric outlet obstruction in PUD?
Inflammatory edema or scar formation near the pylorus.
89What are the clinical manifestations of gastric outlet obstruction?
Early satiety, postprandial vomiting, nausea, and weight loss.
90What is the gold standard diagnostic test for PUD?
Upper gastrointestinal endoscopy (EGD)
91What is the major advantage of EGD in PUD?
Direct visualization and biopsy of ulcers.
92What is the most common invasive test for H. pylori?
Rapid urease test.
93What is the best noninvasive test for active H. pylori infection?
Urea breath test
94What is the sensitivity of the urea breath test?
Greater than 95%.
95What does the urea breath test detect?
Active H. pylori infection through urease activity.
96What isotopes are used in the urea breath test?
$^13C$ or $^14C$ urea.
97What is another noninvasive test for active H. pylori infection?
Stool antigen test.
98Can stool antigen testing confirm H. pylori eradication?
Yes.
99Why is H. pylori antibody testing unsuitable for confirming eradication?
Antibodies may remain positive after the infection has resolved.
100How long should PPIs generally be withheld before H. pylori testing?
At least 2 weeks before urea breath or stool antigen testing.
101What are the three main treatment goals of PUD?
Symptom relief, ulcer healing, and prevention of recurrence and complications.
102What are the components of standard H. pylori triple therapy?
PPI, clarithromycin, and amoxicillin.
103How long is standard H. pylori triple therapy?
14 days.
104What replaces amoxicillin in triple therapy for penicillin-allergic patients?
Metronidazole.
105What does OCA represent in H. pylori treatment?
Omeprazole, clarithromycin, and amoxicillin.
106What are the components of bismuth quadruple therapy?
PPI, bismuth, metronidazole, and tetracycline.
107How long is bismuth quadruple therapy?
10–14 days.
108What does TOMB represent in H. pylori treatment?
Tetracycline, omeprazole, metronidazole, and bismuth.
109When should H. pylori eradication be confirmed?
At least 4 weeks after antibiotic therapy.
110Which tests are recommended for confirming H. pylori eradication?
Urea breath test or stool antigen test.
111Is serology appropriate for confirming H. pylori eradication?
No.
112What is the first step in managing NSAID-induced ulcers?
Discontinue NSAIDs if possible.
113What is the preferred treatment for NSAID-induced ulcers?
Proton pump inhibitors.
114What is the most effective medication for preventing NSAID-induced ulcers?
Proton pump inhibitors
115What is misoprostol?
A prostaglandin analog that protects gastric mucosa.
116What is a common adverse effect of misoprostol?
Diarrhea.
117What is an advantage of selective COX-2 inhibitors?
Lower gastrointestinal injury than nonselective NSAIDs.
118What is an example of a selective COX-2 inhibitor?
Celecoxib.
119What is a major cardiovascular risk of COX-2 inhibitors?
Increased risk of myocardial infarction and stroke.
120When should repeat EGD be performed for gastric ulcers?
After 8–12 weeks to confirm healing.
121When is a gastric ulcer considered refractory?
Failure to heal after 12 weeks.
122When is a duodenal ulcer considered refractory?
Failure to heal after 8 weeks.
123What should be excluded in refractory PUD?
Persistent H. pylori, NSAID use, poor adherence, malignancy, and Zollinger-Ellison syndrome.
124What is spontaneous bacterial peritonitis (SBP)?
Infection of ascitic fluid without an identifiable intra-abdominal source.
125In which patients does SBP most commonly occur?
Patients with cirrhosis and ascites.
126What is the diagnostic ascitic fluid PMN threshold for SBP?
At least 250 cells/mm³
127Can SBP be diagnosed with a negative ascitic fluid culture?
Yes.
128Is SBP usually monomicrobial or polymicrobial?
Monomicrobial.
129What are the most common organisms causing SBP?
E. coli and other enteric gram-negative bacilli.
130What is the preferred empiric antibiotic class for SBP?
Third-generation cephalosporins
131What is the ceftriaxone dose for SBP?
2 g IV every 24 hours.
132What is the cefotaxime dose for SBP?
2 g IV every 8 hours.
133How long is the usual antibiotic treatment for uncomplicated SBP?
At least 5 days.
134What is the main mechanism of SBP development?
Bacterial translocation from the intestine into ascitic fluid.
135Which patients qualify for primary SBP prophylaxis?
High-risk cirrhotic patients with low ascitic fluid protein and renal dysfunction or severe liver failure.
136What ascitic fluid protein level indicates increased SBP risk?
Less than 1.5 g/dL.
137Who requires secondary SBP prophylaxis?
Patients with a previous episode of SBP.
138What is the recurrence risk of SBP without secondary prophylaxis?
Up to 70% within 1 year.
139What antibiotics are used for secondary SBP prophylaxis?
Norfloxacin, ciprofloxacin, or trimethoprim-sulfamethoxazole.
140How long should cirrhotic patients with GI bleeding receive antibiotic prophylaxis?
7 days.
141What is secondary peritonitis?
Peritoneal infection caused by an identifiable intra-abdominal source.
142What are common causes of secondary peritonitis?
Perforated appendicitis, diverticulitis, perforated PUD, bowel ischemia, and anastomotic leakage.
143Is secondary peritonitis usually monomicrobial or polymicrobial?
Polymicrobial.
144What organisms commonly cause secondary peritonitis?
Enteric gram-negative bacilli and anaerobes, especially E. coli and Bacteroides.
145What is the cornerstone of secondary peritonitis management?
Source control
146What procedures achieve source control in secondary peritonitis?
Surgery, drainage, debridement, or repair of the underlying lesion.
147Why are antibiotics alone inadequate for secondary peritonitis?
They do not eliminate the source of contamination.
148What organisms must empiric secondary peritonitis antibiotics cover?
Gram-negative bacilli and anaerobes.
149What is an empiric antibiotic regimen for community-acquired secondary peritonitis?
Ceftriaxone plus metronidazole.
150What is the typical antibiotic duration after adequate source control in secondary peritonitis?
4–7 days.
151What is CAPD-associated peritonitis?
Peritoneal infection occurring as a complication of continuous ambulatory peritoneal dialysis.
152What dialysate WBC count supports CAPD-associated peritonitis?
Greater than 100 WBCs/µL with more than 50% PMNs.
153What is the characteristic appearance of dialysate in CAPD peritonitis?
Cloudy dialysate.
154What organisms commonly cause CAPD-associated peritonitis?
Staphylococcus aureus and coagulase-negative staphylococci.
155What is the preferred route of antibiotic administration for CAPD peritonitis?
Intraperitoneal administration.
156What organisms must empiric CAPD peritonitis treatment cover?
Gram-positive and gram-negative bacteria.
157What antibiotic provides empiric MRSA coverage in CAPD peritonitis?
Vancomycin.
158What is the recommended treatment for fungal CAPD-associated peritonitis?
Immediate catheter removal plus antifungal therapy
159When should catheter removal be considered in bacterial CAPD peritonitis?
Refractory or relapsing infection.
160What is an intra-abdominal abscess?
A localized collection of pus within the abdominal cavity or an abdominal organ.
161What is the most common anaerobe isolated from intra-abdominal infections?
Bacteroides fragilis
162What is the preferred imaging modality for intra-abdominal abscesses?
Abdominal CT scan
163What is the main advantage of CT in abscess diagnosis?
Identifies the location, size, and extent of the abscess and guides drainage.
164What is the cornerstone of intra-abdominal abscess treatment?
Drainage and source control.
165What organisms should empiric intra-abdominal abscess antibiotics cover?
Aerobic gram-negative bacilli and anaerobes.
166What is a common empiric antibiotic regimen for intra-abdominal abscess?
Piperacillin-tazobactam or ceftriaxone plus metronidazole.
167What is the most common reason for intra-abdominal abscess treatment failure?
Inadequate drainage or failure to achieve source control.
168How long are antibiotics generally continued after adequate abscess drainage?
Approximately 4–5 days.
169What is the most commonly affected visceral organ in intra-abdominal abscesses?
Liver
170What is the most common source of hepatic abscess?
Biliary tract disease.
171What is the most common presenting feature of hepatic abscess?
Fever.
172What is the most reliable diagnostic method for hepatic abscess?
Imaging.
173What is the preferred imaging modality for hepatic abscess?
Contrast-enhanced abdominal CT.
174What is the most reliable laboratory abnormality in hepatic abscess?
Elevated alkaline phosphatase.
175What is the most common organism associated with hepatic abscess in Southeast Asia?
Klebsiella pneumoniae
176What organism causes amebic liver abscess?
Entamoeba histolytica.
177What is the mainstay of hepatic abscess treatment?
Drainage plus antimicrobial therapy.
178What is the first-line drainage method for hepatic abscess?
Image-guided percutaneous drainage.
179What type of catheter is commonly used for percutaneous hepatic abscess drainage?
Pigtail catheter.
180When may hepatic abscess be treated with antibiotics alone?
Selected stable patients with small abscesses under 3 cm.
181When is surgical drainage considered for hepatic abscess?
Large or multiple abscesses, unsuitable percutaneous drainage, associated surgical disease, or failed treatment.
182What is a splenic abscess?
A localized infection and pus collection within the spleen.
183What is the most common route of infection in splenic abscess?
Hematogenous spread
184What infection is commonly associated with splenic abscess?
Infective endocarditis.
185What is the most common clinical manifestation of splenic abscess?
Fever.
186What is the most sensitive imaging modality for splenic abscess?
Abdominal CT scan.
187What is the traditional standard treatment for splenic abscess?
Splenectomy plus antibiotics.
188When may percutaneous drainage be considered for splenic abscess?
Single small abscesses or patients at high surgical risk.
189Which vaccines are needed after splenectomy?
Pneumococcal, Haemophilus influenzae type B, and meningococcal vaccines.
190When should vaccines be administered before elective splenectomy?
At least 2 weeks before surgery.
191What is a renal abscess?
A localized collection of pus within the renal parenchyma.
192What is a perinephric abscess?
An abscess located around the kidney within the perirenal space.
193What is the most common source of renal and perinephric abscesses?
Ascending urinary tract infection.
194What is the most important risk factor for renal and perinephric abscesses?
Nephrolithiasis with urinary obstruction
195What is the most common pathogen in renal and perinephric abscesses?
Escherichia coli.
196Which organism produces urease and promotes struvite stone formation?
Proteus species.
197Which organism suggests hematogenous renal abscess, particularly with endocarditis?
Staphylococcus aureus.
198What are the common manifestations of renal or perinephric abscess?
Fever and flank pain.
199When should renal abscess be suspected in a patient treated for pyelonephritis?
Persistent fever after 4–5 days of appropriate therapy.
200What is the most useful diagnostic modality for renal or perinephric abscess?
Contrast-enhanced abdominal CT.
201What is the characteristic CT appearance of a renal abscess?
Hypodense intraparenchymal lesion with an enhancing rim.
202What is the usual drainage treatment for perinephric abscess?
Percutaneous drainage.
203What is the usual antibiotic duration for renal or perinephric abscess?
2–4 weeks, depending on clinical response and source control.
204What underlying problems must be addressed in renal abscess?
Urinary obstruction and nephrolithiasis.